180 Wealth Advisors LLC Grows Holdings in Lam Research Corporation $LRCX

180 Wealth Advisors LLC boosted its position in Lam Research Corporation (NASDAQ:LRCX) by 17.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,475 shares of the semiconductor company’s stock after buying an additional 4,173 shares during the quarter. 180 Wealth Advisors LLC’s holdings in Lam Research were worth $4,874,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. PMV Capital Advisers LLC purchased a new position in Lam Research in the fourth quarter valued at about $25,000. Stance Capital LLC purchased a new stake in Lam Research during the 3rd quarter worth approximately $26,000. Triumph Capital Management purchased a new stake in Lam Research during the 3rd quarter worth approximately $27,000. Harbor Investment Advisory LLC raised its position in shares of Lam Research by 73.9% in the 4th quarter. Harbor Investment Advisory LLC now owns 240 shares of the semiconductor company’s stock valued at $41,000 after purchasing an additional 102 shares in the last quarter. Finally, Howard Hughes Medical Institute acquired a new position in shares of Lam Research in the 2nd quarter valued at approximately $27,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently issued reports on LRCX shares. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Lam Research from $260.00 to $290.00 and gave the stock a “buy” rating in a research note on Thursday, January 29th. The Goldman Sachs Group set a $262.00 price objective on shares of Lam Research and gave the stock a “buy” rating in a report on Thursday, January 29th. New Street Research boosted their target price on shares of Lam Research from $195.00 to $235.00 and gave the stock a “neutral” rating in a research report on Friday, January 30th. B. Riley Financial restated a “buy” rating on shares of Lam Research in a research note on Thursday, January 15th. Finally, Wells Fargo & Company increased their price target on shares of Lam Research from $250.00 to $290.00 and gave the stock an “overweight” rating in a research report on Thursday, January 29th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $245.35.

Insiders Place Their Bets

In other news, Director Eric Brandt sold 35,000 shares of the stock in a transaction on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the transaction, the director owned 253,705 shares of the company’s stock, valued at approximately $57,235,848. This represents a 12.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Douglas R. Bettinger sold 50,057 shares of the firm’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total value of $11,214,269.71. Following the transaction, the chief financial officer directly owned 1,081,705 shares in the company, valued at $242,334,371.15. This trade represents a 4.42% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 130,886 shares of company stock worth $29,658,802. 0.31% of the stock is owned by company insiders.

Lam Research Stock Down 2.4%

LRCX stock opened at $228.36 on Monday. The stock has a market cap of $285.17 billion, a PE ratio of 46.80, a price-to-earnings-growth ratio of 2.46 and a beta of 1.77. The firm’s 50-day simple moving average is $226.92 and its 200 day simple moving average is $178.13. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $256.68. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, topping the consensus estimate of $1.17 by $0.10. The firm had revenue of $5.34 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. Lam Research’s quarterly revenue was up 22.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.91 EPS. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, sell-side analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be given a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date is Wednesday, March 4th. Lam Research’s payout ratio is 21.31%.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.